GILEAD SCIENCES, INC. (GILD)
Clinical trial NCT04296695 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-12-31 → 2025-06-06 3. enrollment: 250 → 202 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04296695 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-12-31 → 2025-06-06 3. enrollment: 250 → 202 participants 4. enrollment type: ESTIMATED → ACTUAL
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical